Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 28
      • May 19, 1994
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 2 8 1
      • Paperback
        9 7 8 0 1 2 3 9 9 4 2 2 6
      • eBook
        9 7 8 0 0 8 0 5 8 1 1 9 4
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both applied and experimental.
    • DNA Topoisomearases: Biochemistry and Molecular Biology

      • 1st Edition
      • Volume 29A
      • September 23, 1994
      • English
      • Paperback
        9 7 8 0 1 2 3 9 9 4 1 1 0
      • Hardback
        9 7 8 0 1 2 0 3 2 9 2 9 8
      • eBook
        9 7 8 0 0 8 0 5 8 1 2 0 0
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both applied and experimental.
    • Progress in Medicinal Chemistry

      • 1st Edition
      • Volume 31
      • April 28, 1994
      • English
      • eBook
        9 7 8 0 0 8 0 8 6 2 7 9 8
      This book contains six chapters, each of which is a self-contained, thorough review by an expert in the field of a particular topic in medicinal chemistry, bacteriology or pharmacology. Each topic is a currently active subject of research in either the quest for new drugs or a better understanding of the role of known biochemical phenomena. In addition, all of the chapters contain an extensive list of relevant reference books, papers and other publications. The book will be of great interest to medicinal and pharmaceutical chemists, and will serve as a valuable source of reference.
    • International Review of Neurobiology

      • 1st Edition
      • Volume 36
      • October 18, 1994
      • English
      • eBook
        9 7 8 0 0 8 0 8 5 7 7 0 1
      Published since 1959, this serial presents in-depth reviews on key topics in neuroscience, from molecules to behavior. The serial stays keenly attuned to recent developments in the field through the contributions offirst-class experts. Neuroscientists as well as clinicians, psychologists, physiologists, and pharmacologists will find this serial an indispensable addition to their library.
    • Advances in Heterocyclic Chemistry

      • 1st Edition
      • Volume 61
      • September 21, 1994
      • English
      • Hardback
        9 7 8 0 1 2 0 2 0 7 6 1 9
      • Paperback
        9 7 8 0 1 2 3 9 9 4 1 3 4
      • eBook
        9 7 8 0 0 8 0 5 7 6 4 8 0
      Established in 1960, Advances in Heterocyclic Chemistry is the definitive serial in the area-one of great importance to organic chemists, polymer chemists, and most biological scientists. Every fifth volume ofAdvances in Heterocyclic Chemistry contains a cumulative subject index.
    • Immunopharmacology of Joints and Connective Tissues

      • 1st Edition
      • January 7, 1994
      • English
      • Hardback
        9 7 8 0 1 2 2 0 6 3 4 5 9
      • eBook
        9 7 8 0 0 8 0 9 1 7 5 8 0
      The consequences for diseases involving the immune system such as AIDS, and chronic inflammatory diseases such as bronchial asthma, rheumatoid athritis, and atherosclerosis, now account for a considerable economic burden to governments worldwide. In response there has been an enormous research effort investigating the basic mechanisms underlying such diseases, and a tremendous drive to identify novel therapeutic applications for their preventions and treatment. Though a plethora of immunological studies have been published in recent years, little has been written about the implications of such research for drug development. As a consequence, this area has not gained the prominence of other new fields such as molecular pharmacology or neuropharmacology, and a focal information source for many pharmacologists interested in diseases of the immune system remains unpublished. The Handbook of Immunopharmacology series provides such a source through the commissioning of a comprehensive collection of volumes on all aspects immunopharmacology. Editors have been sought after for each volume who are not only active in their respective areas of expertise, but who also have distinctly pharmacological bias to their research. The series follows three main themes, each represented by volumes on individual component topics. The first covers each of the major cell types and classes of inflammatory responses that can affect them ("Systems"). The third covers different classes of diseases as well as those under development ("Drugs").
    • Cyclic GMP: Synthesis, Metabolism, and Function

      • 1st Edition
      • Volume 26
      • April 18, 1994
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 2 6 7
      • Paperback
        9 7 8 0 1 2 3 9 9 4 2 5 7
      • eBook
        9 7 8 0 0 8 0 5 8 1 1 7 0
      This volume is dedicated to the topic of cyclic GMP. Chapters include discussions on the guanylyl cyclase and phosphodiesterase isoenzyme families for cyclic GMP synthesis and hydrolysis, cyclic GMP-dependent protein kinases, and various hormones and ligands that regulate cyclic GMP formation and/or metabolism. Several chapters also deal with some of the effects of cyclic GMP on other second messengers such as calcium ion transport and smooth muscle relaxation. Some clinical studies with cyclic GMP and atrial natriuretic peptide are also discussed. The last chapter raises many important questions in the field that remain to be addressed.
    • Analytical Profiles of Drug Substances and Excipients

      • 1st Edition
      • Volume 22
      • November 17, 1993
      • English
      • eBook
        9 7 8 0 0 8 0 8 6 1 1 7 3
      Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The series has recently been expanded to include profiles of excipient materials.